Christian Fiandra

Dr. Christian Fiandra

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2006 in Medical Physics
Verified
Journal Article
Closed access
PDF file
CFChristian Fiandra
Christian Fiandra
URUmberto Ricardi
Umberto Ricardi
RRRiccardo Ragona
Riccardo Ragona
SASilvia Anglesio
Silvia Anglesio
FGFrancesca Romana Giglioli
Francesca Romana Giglioli
FLFrancesco Lucio
Francesco Lucio

2 November 2012 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
CFChristian Fiandra
Christian Fiandra
AFAndrea Riccardo Filippi
Andrea Riccardo Filippi
PCPaola Catuzzo
Paola Catuzzo
ABAngela Botticella
Angela Botticella
PCPatrizia Ciammella
Patrizia Ciammella
URUmberto Ricardi
Umberto Ricardi
Radiotherapy in Hodgkin’s Lymphoma (HL) is currently evolving with new attempts to further reduce radiation volumes to the involved-node concept (Involved Nodes Radiation Therapy, INRT) and with the use of intensity modulated radiotherapy (IMRT). Currently, IMRT can be planned and delivered with several techniques, and its role is not completely clear. We designed a planning study on a typical dataset drawn from clinical routine with the aim of comparing different IMRT solutions in terms of plan quality and treatment delivery efficiency. A total of 10 young female patients affected with early stage mediastinal HL and treated with 30 Gy INRT after ABVD-based chemotherapy were selected from our database. Five different treatment techniques were compared: 3D-CRT, VMAT (single arc), B-VMAT (“butterfly”, multiple arcs), Helical Tomotherapy (HT) and Tomodirect (TD). Beam energy was 6 MV, and all IMRT planning solutions were optimized by inverse planning with specific dose-volume constraints on OAR (breasts, lungs, thyroid gland, coronary ostia, heart). Dose-Volume Histograms (DVHs) and Conformity Number (CN) were calculated and then compared, both for target and OAR by a statistical analysis (Wilcoxon’s Test). PTV coverage was reached for all plans (V95% ≥ 95%); highest mean CN were obtained with HT (0.77) and VMAT (0.76). B-VMAT showed intermediate CN mean values (0.67), while the lowest CN were obtained with TD (0.30) and 3D-CRT techniques (0.30). A trend of inverse correlation between higher CN and larger healthy tissues volumes receiving low radiation doses was shown for lungs and breasts. For thyroid gland and heart/coronary ostia, HT, VMAT and B-VMAT techniques allowed a better sparing in terms of both Dmean and volumes receiving intermediate-high doses compared to 3D-CRT and TD. IMRT techniques showed superior target coverage and OAR sparing, with, as an expected consequence, larger volumes of healthy tissues (lungs, breasts) receiving low doses. Among the different IMRT techniques, HT and VMAT showed higher levels of conformation; B-VMAT and HT emerged as the planning solutions able to achieve the most balanced compromise between higher conformation around the target and smaller volumes of OAR exposed to lower doses (typical of 3D-CRT).

20 December 2017 in Medical Physics
Verified
Journal Article
Closed access
PDF file
GLGianfranco Loi
Gianfranco Loi
MFMarco Fusella
Marco Fusella
ELEleonora Lanzi
Eleonora Lanzi
ECElisabetta Cagni
Elisabetta Cagni
CGCristina Garibaldi
Cristina Garibaldi
CFChristian Fiandra
Christian Fiandra

9 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
FAFrancesca Arcadipane
Francesca Arcadipane
PSPatrick Silvetti
Patrick Silvetti
FOFrancesco Olivero
Francesco Olivero
AGAlessio Gastino
Alessio Gastino
VLViola De Luca
Viola De Luca
Pierfrancesco FrancoPierfrancesco Franco
Pierfrancesco Franco
Purpose: to investigate the role of selective avoidance of hematopoietically active BM within the pelvis, as defined with 18FDG-PET, employing a targeted IMRT approach, to reduce acute hematologic toxicity (HT) profile in anal cancer patients undergoing concurrent chemo-radiation. Methods: a one-armed two-stage Simon’s design was selected to test the hypothesis that BM-sparing approach would improve by 20% the rate of G0–G2 (vs. G3–G4) HT, from 42% of RTOG 0529 historical data to 62% (α = 0.05 and the β = 0.20). At the first stage, among 21 enrolled patients, at least 9 should report G0–G2 acute HT to further proceed with the trial. We employed 18FDG-PET to identify active BM within the pelvis. Acute HT was assessed via weekly blood counts and scored as per the Common Toxicity Criteria for Adverse Effects version 4.0. Results: from December 2017 to October 2019, 21 patients were enrolled. Maximum observed acute HT comprised 9% rate of ≥G3 leukopenia and 5% rate of ≥G3 neutropenia and anemia. Overall, only 4 out of 21 treated patients (19%) experienced ≥G3 acute HT. Conversely, 17 patients (81%) experienced G0–G2 events, way above the threshold set by the trial design. Conclusion: 18FDG-PET-guided BM-sparing IMRT was able to reduce acute HT in anal cancer patients treated with concomitant chemo-radiation. These results prompted us to conclude the second part of this prospective phase II trial.

26 July 2013 in Medical Physics
Verified
Journal Article
Closed access
PDF file
CFChristian Fiandra
Christian Fiandra
MFMarco Fusella
Marco Fusella
FGFrancesca Romana Giglioli
Francesca Romana Giglioli
AFAndrea Riccardo Filippi
Andrea Riccardo Filippi
CMCristina Mantovani
Cristina Mantovani
RRRiccardo Ragona
Riccardo Ragona

1 June 2018 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
Pierfrancesco FrancoPierfrancesco Franco
Pierfrancesco Franco
FAFrancesca Arcadipane
Francesca Arcadipane
ETElisabetta Trino
Elisabetta Trino
EGElena Gallio
Elena Gallio
SMStefania Martini
Stefania Martini
URUmberto Ricardi
Umberto Ricardi
Delineation of treatment volumes is a major source of uncertainties in radiotherapy (RT). This is also true for rectal cancer patients undergoing neoadjuvant RT, with a potential impact on treatment quality. We investigated the role of the digital platform Anatom-e (Anatom-e Information Sytems Ltd., Houston, Texas) in increasing the compliance to follow a specific treatment protocol in a multicentric setting. Two clinical cases of locally advanced rectal cancer were chosen. Participants were instructed to follow the 2009 Radiation Therapy Oncology Group consensus atlas and asked to manually segment clinical target volumes (CTVs), for both patient 1 and 2, on day 1 with and without the use of Anatom-e. After one week (day 2), the same radiation oncologist contoured again, with and without Anatom-e, the same CT series. Intraobserver (Intra-OV) and interobserver (Inter-OV) variability were evaluated with the Dice similarity coefficient (DSC), the Hausdorff distance (HD) and mean distance to agreement (MDA). For clinical case 1, no significant difference was found for Intra-OV and Inter-OV. For clinical case 2, no significant difference was found for Intra-OV but a statistically significant difference was found for Inter-OV in DSC when using or not the platform. Mean DCS was 0.65 (SD: ±0.64; range: 0.58-0.79) for day 1 vs reference volume without Anatom-e and 0.72 (SD: ±0.39; range: 0.67-0.77) (p = 0.03) with it. Mean MDA was lower with Anatom-e (3.61; SD: ±1.33; range: 2.85-4.78) than without (4.14; SD: ±2.97; range: 2.18-5.21), with no statistical significance (p = 0.21) The use of Anatom-e decreased the SD from 2.97 to 1.33. Mean HD was lower with Anatom-e (26.06; SD: ±2.05; range: 24.08-32.62), with no statistical significance (p = 0.14) compared to that without (31.39; SD: ±1.31; range: 26.14-48.72). The use of Anatom-e decreased the Inter-OV in the CTV delineation process for locally advanced rectal cancer with complex disease presentation planned for neoadjuvant RT. This system may be potentially helpful in increasing the compliance to follow shared guidelines and protocols.